Vbi Vaccines Inc CS(VBIV-Q)NASDAQ
Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
After Hours Change
After Hours Last Update After Hours Price
Volume
Vbi Vaccines Inc CS
160 Second Street Floor 3Cambridge MA 02142 USA
P: 617-830-3031
http://www.vbivaccines.com
Sectors & Indices
Sector
Industry
Employees
Profile
VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.
Key Executives
Name | Title |
---|---|
Avi Mazaltov | General Manager, Subsidiary/Other Corporate Officer |
Jeffrey R. Baxter | CEO/Director/President |
David E. Anderson | Chief Scientific Officer |
Nell Beattie | CFO/Director/Other Corporate Officer |
Francisco Diaz-Mitoma | Chief Medical Officer |
John Robert Dillman | Other Executive Officer |